The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

DICP, The Annals of Pharmacotherapy: Vol. 24, No. 7, pp. 705-706.
© 1990 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krick, S.
Right arrow Articles by Cooper, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krick, S.
Right arrow Articles by Cooper, G.

Research Articles

Severe verapamil (sustained-release) overdose

SE Krick, JG Gums, K Grauer, and GR Cooper

Vasodilators, specifically calcium-channel modulators, are currently in widespread use for the treatment of essential hypertension. Several reports of toxicity from immediate-release verapamil have appeared in the literature. We present a case of sustained-release verapamil overdose as a consequence of an attempted suicide. The treatment measures used in a verapamil toxicity are discussed, as well as a review of the current literature on verapamil overdose.


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
A Tracqui, C Tournoud, P Kintz, M Villain, C Kummerlen, P Sauder, and B Ludes
HPLC/MS findings in a fatality involving sustained-release verapamil
Human and Experimental Toxicology, September 1, 2003; 22(9): 515 - 521.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1990 by Harvey Whitney Books Company.